RecruitingPhase 4NCT07240077

Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia

Beta-lactam Monotherapy Versus Beta-lactam Plus Levofloxacin for the Treatment of Streptococcal Bacteremia: A Multicenter, Randomized, Double-Blind, Pragmatic Trial

Sponsor

Mahidol University

Enrollment

165 participants

Start Date

Jan 8, 2026

Study Type

INTERVENTIONAL

Conditions

Bacteremia Streptococcus Infection

Summary

A double-blind randomized controlled trial comparing beta-lactam plus levofloxacin versus beta-lactam monotherapy for the treatment of Streptococcal bacteremia

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Beta-lactam monotherapy and a drug called Beta-lactam plus levofloxacin combination therapy for people with bacteremia and streptococcus infection. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.